Shares of Carl Zeiss Meditec AG (ETR:AFX – Get Free Report) were down 0.9% on Wednesday . The company traded as low as €42.68 and last traded at €42.94. Approximately 111,065 shares traded hands during mid-day trading, an increase of 18% from the average daily volume of 94,405 shares. The stock had previously closed at €43.32.
Carl Zeiss Meditec Stock Performance
The stock has a market capitalization of $4.00 billion, a P/E ratio of 22.95, a P/E/G ratio of 2.83 and a beta of 0.98. The stock has a 50 day simple moving average of €44.16 and a two-hundred day simple moving average of €48.51. The company has a quick ratio of 2.47, a current ratio of 2.13 and a debt-to-equity ratio of 7.41.
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Featured Stories
- Five stocks we like better than Carl Zeiss Meditec
- Industrial Products Stocks Investing
- 3 Stocks Poised to Benefit From Google’s AI Breakthough
- Insider Trades May Not Tell You What You Think
- Beyond NVIDIA: 5 Semiconductor Stocks Set to Dominate 2026
- How to Profit From Growth Investing
- 3 Stocks You’ll Wish You Bought Before 2026
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
